Thymulin vs Thymopentin

Both are defined thymic peptides, but from different parent hormones. Thymulin’s activity depends on zinc binding; thymopentin is a short active fragment of thymopoietin.

HPLC tested · JanoshikJanoshik CertificatesNationwide DeliveryResearch Only

🧪

Thymulin

A zinc-dependent nonapeptide hormone produced only by thymic epithelial cells, studied for immune and neuroendocrine regulation.

BEST STUDIED FOR

Repair & immune

Read the cited profile →

🧪

Thymopentin

A synthetic pentapeptide matching the active site (residues 32–36) of the thymic hormone thymopoietin, studied as an immunomodulator.

BEST STUDIED FOR

Repair & immune

Read the cited profile →

SIDE BY SIDE

	Thymulin	Thymopentin
The key difference	Zinc-bound nonapeptide	Thymopoietin pentapeptide
Class	Repair & immune	Repair & immune
Mechanism	Thymulin needs bound zinc for activity; it promotes T-cell differentiation and interacts with the neuroendocrine system.	Thymopentin reproduces thymopoietin’s activity on T-cell differentiation and immune balance; it was investigated in atopic dermatitis, rheumatoid arthritis and immunodeficiency in the 1980s.
Status	Preclinical and physiological research; not an approved medicine.	Registered in some countries historically; mostly 1980s–90s clinical research, with renewed interest in hybrid peptides.
Reported safety signals	No human therapeutic safety data.	A 1985 overview of its preclinical safety programme reported a favourable profile.
A key study	Reviews thymulin production by thymic epithelium and its neuroendocrine regulation. (Curr Pharm Des 2014, PMID 24588820)	Describes thymopentin as the active-site pentapeptide (residues 32–36) of thymopoietin. (Surv Immunol Res 1985, PMID 2994196)

WHEN TO RESEARCH WHICH

Both suit T-cell-differentiation research; neither is widely approved. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.

REFERENCES (PUBMED)

[Thymulin] Physiology and therapeutic potential of the thymic peptide thymulin — Curr Pharm Des 2014. PMID 24588820
[Thymulin] Thymulin, a zinc-dependent hormone — Med Oncol Tumor Pharmacother 1989. PMID 2657247
[Thymulin] Immunomodulatory role of thymulin in lung diseases — Expert Opin Ther Targets 2010. PMID 20055713
[Thymopentin] Thymopoietin to thymopentin: experimental studies — Surv Immunol Res 1985. PMID 2994196
[Thymopentin] Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis — J Am Acad Dermatol 1983. PMID 6339571
[Thymopentin] Thymopentin and splenopentin as immunomodulators. Current status — Immunol Res 1998. PMID 9638477

FREQUENTLY ASKED

What is the difference between Thymulin and Thymopentin?

Both are defined thymic peptides, but from different parent hormones. Thymulin’s activity depends on zinc binding; thymopentin is a short active fragment of thymopoietin.

What is the regulatory status of Thymulin and Thymopentin?

Thymulin: Preclinical and physiological research; not an approved medicine. Thymopentin: Registered in some countries historically; mostly 1980s–90s clinical research, with renewed interest in hybrid peptides.

What safety signals have been reported?

Thymulin: No human therapeutic safety data. Thymopentin: A 1985 overview of its preclinical safety programme reported a favourable profile.

Which studies is this comparison based on?

For Thymulin: “Physiology and therapeutic potential of the thymic peptide thymulin” (PMID 24588820); “Thymulin, a zinc-dependent hormone” (PMID 2657247); “Immunomodulatory role of thymulin in lung diseases” (PMID 20055713). For Thymopentin: “Thymopoietin to thymopentin: experimental studies” (PMID 2994196); “Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis” (PMID 6339571); “Thymopentin and splenopentin as immunomodulators. Current status” (PMID 9638477).